pramipexole dihydrochloride tablet extended release pramipexole dihydrochloride pramipexole dihydrochloride tablet extended release
1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson's disease. Pramipexole dihydrochloride extended-release tablet is a non-ergot dopamine agonist indicated for the treatment of Parkinson’s disease (PD) (1)
dr. reddy's laboratories limited
Related Pills
24 HR Pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet
dr. reddy's laboratories limited
24 HR Pramipexole dihydrochloride 3 MG Extended Release Oral Tablet
dr. reddy's laboratories limited
24 HR Pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet
dr. reddy's laboratories limited
24 HR Pramipexole dihydrochloride 0.375 MG Extended Release Oral Tablet
dr. reddy's laboratories limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
PRAMIPEXOLE DIHYDROCHLORIDE extended-release tablets are available as follows: 0. 375 mg: Off white, round shaped, biconvex, uncoated tablet, debossed with 'RDY' on one side and '611' on other side and are supplied in bottle of 30’s count. Bottles of 30 NDC 55111-611-30 0.75 mg: Off white, round shaped, biconvex, uncoated tablet, debossed with 'RDY' on one side and '612' on other side and are supplied in bottle of 30’s count. Bottles of 30 NDC 55111-612-30 1.5 mg: Off white, oval shaped, biconvex, uncoated tablet, debossed with 'RDY' on one side and '613' on other side and are supplied in bottle of 30’s count. Bottles of 30 NDC 55111-613-30 3 mg: Off white, oval shaped, biconvex, uncoated tablet, debossed with 'RDY' on one side and '614' on other side and are supplied in bottle of 30’s count. Bottles of 30 NDC 55111-614-30 4.5 mg: Off white, oval shaped, biconvex, uncoated tablet, debossed with 'RDY' on one side and '615' on other side and are supplied in bottle of 30’s count. Bottles of 30 NDC 55111-615-30 16.2 Storage and Handling ÂÂStore at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from exposure to high humidity. Store in a safe place out of the reach of children.
More pills like ROUND RDY 612